This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Exercise Versus Cognitive Behavioural Therapy on Cancer-related Fatigue

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2010 by Charite University, Berlin, Germany.
Recruitment status was:  Recruiting
Information provided by:
Charite University, Berlin, Germany Identifier:
First received: December 17, 2009
Last updated: March 29, 2010
Last verified: March 2010
The investigators compare the effects of two interventions, an endurance exercise program and a cognitive behavioural therapy, on the fatigue, quality of life, mood and physical performance of patients with a cancer-related fatigue syndrome. The intervention will be carried out for 4 weeks. Tests will be carried out at the beginning and at the end of the study.

Condition Intervention Phase
Fatigue Mood Maximal Oxygen Uptake Behavioral: Exercise Behavioral: Cognitive behavioural therapy Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Care Provider)
Primary Purpose: Treatment
Official Title: Effects of a Brief Endurance Exercise Program and of a Cognitive Behavioural Therapy on Patients With Cancer-related Fatigue

Resource links provided by NLM:

Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Fatigue scores on the Brief Fatigue Inventory (BFI) [ Time Frame: 4 weeks ]

Secondary Outcome Measures:
  • Maximal oxygen uptake (VO2max) on a treadmill stress test. [ Time Frame: 4 weeks ]
  • Scores on the HADS (Hospital Anxiety and Depression Scale) [ Time Frame: 4 weeks ]

Estimated Enrollment: 60
Study Start Date: December 2009
Estimated Study Completion Date: September 2010
Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Cognitive behavioural therapy Behavioral: Cognitive behavioural therapy
Teaching of techniques to reduce fatigue and to improve stamina
Experimental: Exercise
Endurance training (walking on a treadmill) 3 x weekly for 4 weeks
Behavioral: Exercise
Endurance exercise 3 times weekly for 45 minutes, 4 weeks long


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 18-70
  • Histologically confirmed neoplastic disease
  • Treatment (chemotherapy or radiation) completed.
  • No treatment in the previous 4 weeks
  • Ability to understand written German

Exclusion Criteria:

  • Health conditions which can be aggravated by exercise
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01035203

Contact: Fernando Dimeo, MD +493084452098

Department of Sports Medicine Recruiting
Berlin, Germany, 14167
Contact: Fernando Dimeo, MD    +493084452098   
Contact: Susanne Effenberger    +493084454834   
Sponsors and Collaborators
Charite University, Berlin, Germany
  More Information

Responsible Party: Fernando Dimeo, MD, Charité Universitätsmedizin Berlin Identifier: NCT01035203     History of Changes
Other Study ID Numbers: 176-25/kmo
Study First Received: December 17, 2009
Last Updated: March 29, 2010

Additional relevant MeSH terms:
Signs and Symptoms processed this record on September 20, 2017